NR3C1 and Hyperglycemia: Actually, it is due to the GR agonism-mediated gluconeogenesis activation that treatment of GR agonist like dexamethasone (Dex) clinically may cause increased gluconeogenesis and hyperglycemia, which makes the limitation of GR activator usage [16, 17].